MYC Degradation
Open accessThe DOI matches its Crossref record; 111 of the 114 references it cites were found in a registry or an index.
Abstract
The MYC oncoprotein is an essential transcription factor that regulates the expression of many genes involved in cell growth, proliferation, and metabolic pathways. Thus, it is important to keep MYC activity in check in normal cells in order to avoid unwanted oncogenic changes. Normal cells have adapted several ways to control MYC levels, and these mechanisms can be disrupted in cancer cells. One of the major ways in which MYC levels are controlled in cells is through targeted degradation by the ubiquitin-proteasome system (UPS). Here, we discuss the role of the UPS in the regulation of MYC protein levels and review some of the many proteins that have been shown to regulate MYC protein stability. In addition, we discuss how this relates to MYC transcriptional activity, human cancers, and therapeutic targeting.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We show that DT-061 binds a unique heterotrimeric regulatory pocket to selectively stabilize the B56α-PP2A holoenzyme thereby inducing cell death and attenuating tumor growth through B56α directed substrate dephosphorylation, including its most well characterized substrate, the oncogenic protein c-MYC (Allen-Petersen et al., 2018; Arnold and Sears, 2006; Farrell and Sears, 2014; Sheppard et al., 2”
From Selective PP2A enhancement through biased heterotrimer stabilization (2020) · cites this paper as Farrell and Sears, 2014
Citations
Cites
Function and regulation of cullin–RING ubiquitin ligases
Petroski, M. D., & Deshaies, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1547 · Cited by 2,148
Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. (2005) · Nature Genetics · doi:10.1038/ng1531 · Cited by 1,923
A genomic and functional inventory of deubiquitinating enzymes.
Nijman, S. M. B., Luna-Vargas, M. P. A., Velds, A., Brummelkamp, T. R., Dirac, A. M. G., Sixma, T. K., & Bernards, R. (2005) · Cell · doi:10.1016/j.cell.2005.11.007 · Cited by 1,854
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with Myc
Blackwood, E. M., & Eisenman, R. N. (1991) · Science · doi:10.1126/science.2006410 · Cited by 1,697
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Lin, C. Y., Lovén, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.08.026 · Cited by 1,513
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,393
Self-citationc-Myc Regulates Transcriptional Pause Release
Rahl, P. B., Lin, C. Y., Seila, A. C., Flynn, R. A., McCuine, S., Burge, C. B., Sharp, P. A., & Young, R. A. (2010) · Cell · doi:10.1016/j.cell.2010.03.030 · Cited by 1,279
SCF and Cullin/RING H2-Based Ubiquitin Ligases
Deshaies, R. J. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.435 · Cited by 1,242
MYC oncogenes and human neoplastic disease
Nesbit, C. E., Tersak, J. M., & Prochownik, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202746 · Cited by 1,158
Cited by
Items 401–471 of 471
Autophagy genes CCL2 and MYC are considered as potential biomarkers for pulmonary embolism.
Zhang, X., Yang, N., Shao, L., Chen, X., & Chen, X. (2022) · PubMed · Cited by 1
Wei, S., Yang, I., Martinez, G. M., Yang, S., Cho, E. J., Dalby, K. N., & Kang, M. H. (2020) · doi:10.22541/au.160331923.36989531/v1
Yang, R., Wang, W., Dong, M., Roso, K., Greer, P. K., Bao, X., Pirozzi, C. J., Bigner, D. D., Yan, H., Ashley, D. M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.07.447394 · Cited by 1
Direct RNA-binding by MYCN mediates feedback from RNA processing to transcription controlPreprint
Papadopoulos, D., Ha, S. A., Fleischhauer, D., Uhl, L., Schneider, K., Mikičić, I., Russell, T. J., Brem, A., Valanju, O. R., Gallant, P., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.16.553474 · Cited by 1
Control of MYC-dependent apoptotic threshold by a co-amplified ubiquitin E3 ligase UBR5Preprint
Qiao, X., Liu, Y., Prada, M. L., Gupta, A., Jaiswal, A., Sharma, M., Haikala, H. M., Talvinen, K., Yetukuri, L., Pylvänäinen, J. W., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/515247
c-Myc Metabolic Addiction in Cancers Counteracted by Resveratrol and NQO2
Hsieh, T., Doonan, B. B., & WU, J. M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.77852
Max deletion destabilizes MYC protein and abrogates Eμ- Myc lymphomagenesisPreprint
Mathsyaraja, H., Freie, B. W., Cheng, P.-F., Babaeva, E., Janssens, D. H., Henikoff, S., & Eisenman, R. N. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/556522
“The rate of MYC protein degradation is mediated by several factors that interfere with signals triggering MYC ubiquitination and proteasomal degradation (Farrell and Sears, 2014).”
BackgroundResearch progress in structure and function of polymerase-associated factor 1 complex
Long, J., Zhou, H., & FeiLong, C. H. E. N. (2019) · Scientia Sinica Vitae · doi:10.1360/ssv-2019-0154
Tadele, D. S., Robertson, J. M., Crispin, R., Herrera, M. C., Chlubnová, M., Piechaczyk, L., Durán, P. A., Singh, S. K., Gedde‐Dahl, T., Fløisand, Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.16.089755
Mahani, A., Arvidsson, G., Sadeghi, L., Grandien, A., & Wright, A. P. H. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.13.200238
“[13] Proteins carrying the T58A mutation have been shown to be stabilized while MYC proteins carrying T58I are surprisingly similar to WT in terms of half-life indicating that additional mechanisms affecting MYC protein levels are affected when the threonine residue at position T58 is altered to…”
BackgroundSmall-molecule Inhibitors of Myc–Max Interaction and DNA Binding
Fletcher, S., & Prochownik, E. V. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016544-00302
Antino, M., Rodríguez, F. G., Rodríguez‐Muñoz, A., & Borzillo, S. (2014) · International Journal of Social Psychology Revista de Psicología Social
Leslie, N. R., & Porcza, L. M. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737998700.793575573
Molina, E., García-Gutiérrez, L., Junco, V., Pérez‐Olivares, M., de Yébenes, V. G., Blanco, R. E., Quevedo, L., Acosta, J. C., Marín, A. V., Ulgiati, D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.28.522143
“Besides translocations, 30-50% of BL also carry mutations within the MYC gene [23], most of them generating a more stable MYC protein [24].”
BackgroundSim, D. Y., Lee, H., Ahn, C., Park, J.-E., Park, S., Shim, B., Kim, B., & Kim, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3143964/v1
Xiang, B., Liu, Y., Meng, H., Cai, J., Chen, Q., Chen, P., Zeng, Z., Li, G., Xiong, W., Fan, S., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3017766/v1
ANGGRAENI, I. G., & Pithi Chanvorachote, B. (2022) · Chula Digiverse · doi:10.58837/chula.the.2022.290
“The first phase in this process involves the attachment of ubiquitin molecules to the proteins that are being degraded, and the second step involves the degradation of polyubiquitinated proteins by 26s proteasomes that contain at least four ubiquitin molecules each (70).”
BackgroundSriratanasak, N., Chanvorachote, P., & Luanpitpong, S. (2019) · Chula Digiverse · doi:10.58837/chula.the.2019.428
Yuan, T., Kumar, S., Skinner, M. E., Victor-Joseph, R., Abuaita, M., Keijer, J., Zhang, J., Kunkel, T. J., Liu, Y., Petrunak, E. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.06.570371
Overexpression of deubiquitinase (usp 36) in oral squamous cell carcinoma
Murali, P., Kavitha, B., & Narasimhan, M. (2023) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_311_23
“19-23] Myc stability is tightly controlled by the ubiquitin-proteasome system.”
BackgroundUndruggable oncoproteins cMyc and NMyc bind to mediator of transcription with superior high affinityPreprint
Knight, A., Houser, J., Otaševič, T., Juráň, V., Vybíhal, V., Smrčka, M., & Piskáček, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.15.585150
“Besides the attempts to target Myc directly, another approach was to suppress MYC activity by targeting factors regulating MYC degradation [43], alternative strategies target MYC stability or blocking its interaction between acetylated histones and the bromodomain protein BRD4 [44].”
BackgroundWang, Y., Xue, S., Liu, Q., Gao, D., Hua, R., & Lei, M. (2023) · Figshare · doi:10.6084/m9.figshare.22631464
Wang, Y., Xue, S., Liu, Q., Gao, D., Hua, R., & Lei, M. (2023) · Figshare · doi:10.6084/m9.figshare.22631467
Wang, Y., Xue, S., Liu, Q., Gao, D., Hua, R., & Lei, M. (2023) · Figshare · doi:10.6084/m9.figshare.22631458
Wang, Y., Xue, S., Liu, Q., Gao, D., Hua, R., & Lei, M. (2023) · Figshare · doi:10.6084/m9.figshare.22631461
Regulation of Gene Expression by the MYC Transcription Factor Network during Exercise
Astratenkova, I. V., Golberg, N. D., & Rogozkin, V. A. (2023) · Human Physiology · doi:10.31857/s0131164622601014
CoREST Complex Stabilizes MYC Protein to Promote Cancer Cell Genome StabilityPreprint
Khan, A. A., Kim, S., Sidrat, T., Byun, J., Aptekmann, A. A., Dalerba, P. D., Zakrzewski, J. L., Shin, J., & Ryu, B. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.23.630174
Heterobifunctional proteomimetic polymers for targeted protein degradationPreprint
Wang, M. M., Truica, M. I., Gattis, B. S., Oktawiec, J., Sagar, V., Basu, A. A., Bertin, P. A., Zhang, X., Abdulkadir, S. A., & Gianneschi, N. C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.07.641543
“This observation could partially be attributed to the stability of HYDRACs, but is also consistent with a catalytic mode of action, as the rapid turnover of MYC would otherwise be expected to quickly exhaust the small amount of internalized HYDRAC 49 .”
Kral, A. J., Jia, L., Sim, G., Wan, L., & Krainer, A. R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.14.648775
“This observation supports the model that AURKA stabilizes MYC by masking its phospho-T58 degradation signal, such that its depletion exposes MYC to proteasomal degradation 30,74 .”
Llombart, V., O’Connor, D., Demeulemeester, J., Bhamra, A., Šurinová, S., Turňa, A., Fung, K. T. M., Wang, L., Li, Y., Rapoz-D’Silva, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.16.659507
Bao, X., Abdullaev, Z., Das, S., Zgonc, V., Ylaya, K., Pittaluga, S., Hewitt, S. M., Sedivy, J. M., Pack, S. J., Mackem, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.28.667174
“…to gene amplification, chromosomal rearrangements juxtaposing MYC with immunoglobulin or other super-enhancers, viral insertions or other transcription-activating signals ectopically transduced to the MYC locus, or by mutations that stabilize the normally short-lived MYC protein (14) or RNA (15).”
Huang, B. J., D’Souza, J., Batingana, A. R., Harris, M., Wang, X., Hwang, E., Wandler, A. M., Burgess, M. R., Li, Q., Meshinchi, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.13.688312
Fu, W., Wu, Q., Yao, Y., Sun, Y., Wang, H., Jie, J., Zheng, X., Wang, L., Hu, X., Tong, X., et al. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168138
Wang, Y., Xue, S., Liu, Q., Gao, D., Hua, R., & Lei, M. (2023) · Figshare · doi:10.6084/m9.figshare.22631449
Wang, Y., Xue, S., Liu, Q., Gao, D., Hua, R., & Lei, M. (2023) · Figshare · doi:10.6084/m9.figshare.22631455
Wang, Y., Xue, S., Liu, Q., Gao, D., Hua, R., & Lei, M. (2023) · Figshare · doi:10.6084/m9.figshare.22631446
Perumal, N., Kanchan, R. K., Doss, D., Bastola, N., Atri, P., Chirravuri‐Venkata, R., Thapa, I., Vengoji, R., Maurya, S. K., Klinkebiel, D., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17283992
Wang, Y., Xue, S., Liu, Q., Gao, D., Hua, R., & Lei, M. (2023) · Figshare · doi:10.6084/m9.figshare.22631452
Perumal, N., Kanchan, R. K., Doss, D., Bastola, N., Atri, P., Chirravuri‐Venkata, R., Thapa, I., Vengoji, R., Maurya, S. K., Klinkebiel, D., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17284001
Perumal, N., Kanchan, R. K., Doss, D., Bastola, N., Atri, P., Chirravuri‐Venkata, R., Thapa, I., Vengoji, R., Maurya, S. K., Klinkebiel, D., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17283998
Perumal, N., Kanchan, R. K., Doss, D., Bastola, N., Atri, P., Chirravuri‐Venkata, R., Thapa, I., Vengoji, R., Maurya, S. K., Klinkebiel, D., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17283995
Perumal, N., Kanchan, R. K., Doss, D., Bastola, N., Atri, P., Chirravuri‐Venkata, R., Thapa, I., Vengoji, R., Maurya, S. K., Klinkebiel, D. L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17283989
Zhu, X., Li, C., Gao, Y., Zhang, Q., Wang, T., Zhou, H., Bu, F., Chen, J., Mao, X., He, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24923721
Perumal, N., Kanchan, R. K., Doss, D., Bastola, N., Atri, P., Chirravuri‐Venkata, R., Thapa, I., Vengoji, R., Maurya, S. K., Klinkebiel, D., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17283983
Perumal, N., Kanchan, R. K., Doss, D., Bastola, N., Atri, P., Chirravuri‐Venkata, R., Thapa, I., Vengoji, R., Maurya, S. K., Klinkebiel, D., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17283986
DSN1 promotes colorectal cancer metastasis by Inhibiting FZR1-Mediated ubiquitination of c-MYC
Zhang, C., Yuan, Z., Hu, H., Cy, W., Wang, J., Xiang, J., Zhang, N., Li, W., Yu, S., Galiullin, D., et al. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.114944
Ubiquitin-Proteasome System in the Cellular Proteostasis
Soni, S., Tiwari, A. K., & Upadhyay, A. (2026) · Springer eBooks · doi:10.1007/978-981-95-6099-8_6
Switching of the c-Myc protein degradation pathway depending on the PP2A-B55α complex levels
Ando, S., Ikeda, S., Tanaka, K., Tomabechi, Y., Yamagata, A., Shirouzu, M., Tsunedomi, R., Nagano, H., Tsuji, S., Sato, K., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2509374123
Stability of c-Myc Protein in Early S Phase Is Regulated by the Interaction with PCNA
Cardano, M., Cazzalini, O., Maraventano, G., Stivala, L. A., Zannini, L., & Prosperi, E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062745
“Although other E3 ubiquitin ligases have been implicated in c-Myc degradation [31,32], a complex containing DDB1-CUL4A has previously been shown to regulate c-Myc stability via the substrate receptor TRUSS [33].”
Nanobody‐Mediated c‐MYC Degradation Inhibits Tumor Cell Progression
Xue, Y., Jiang, H., Zong, Z., Tian, X., Miao, Z., Li, T., Wei, Y., & Deng, H. (2026) · MedComm · doi:10.1002/mco2.70701
“In particular, strategies that promote phosphorylation-dependent proteasomal turnover of c-MYC could provide deeper and more durable suppression of MYC-driven oncogenic programs [ 40, 41 ].”
Hirofuji, A., Tanaka, H., Tsujita, Y., Okubo, R., Ushioda, R., Fujii, Y., Yusuke, O. N. O., Hashimoto, M., Kanao-Kanda, M., Mizukami, Y., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.046146
“46 To address this limitation, we used anti-GFP immunofluorescence as a surrogate for AAV9 transduction.”
Liu, H., Wang, Y., Liu, X., Yang, N., Wang, S., Zhao, J., Shi, Y., Wang, H. W., & Ma, Y. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.117852
Jiang, T., Jiang, S., Cheng, Y., Yu, X., Chen, Z., Li, H., Cao, S., 项忠元, Zhao, R., Yi, W., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.05.001
Akt-mediated RALY phosphorylation functions as a molecular switch governing c-Myc stability
Yu, N., Zhao, K., Wu, X., Yao, B., Guo, X., Tang, S., Hu, H., Wang, Z., Wang, N., & Mei, Y. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01773-y
Thompson, E. M., Patel, V., Karapouliou, C., Rajeeve, V., Cutillas, P. R., & Stoker, A. W. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.07.730727
Chemical Induction of MYC Protein Degradation via MYC–MAX Disruption and 20S Proteasome Activation
Olatunde, M. O., & Tepe, J. J. (2026) · ACS Chemical Biology · doi:10.1021/acschembio.6c00258
Henchy, C., Wang, H., & Prochownik, E. V. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.22.733817
“Fourth, DNA binding around TSSs and TESs markedly stabilizes MYC, increasing its mean half-life from the standardly accepted 20-30 min to >24-48 hr (27, 72).”
Miyake, F., Ishihara, S., Ando, N., Tange, S., Enomoto, A., & Haga, H. (2026) · PLoS ONE · doi:10.1371/journal.pone.0352769
“Previous studies have reported that ubiquitinated Myc is degraded by proteasome [25,31–33] and triggered by phosphorylation in Myc at T58 induced by GSK3 [25].”
Wood, O., Braithwaite, A. T., Fisher, J., Li, L., Murray, L., Paluch, C., & Jackson, M. A. (2026) · Genome Medicine · doi:10.1186/s13073-026-01721-y · Cited by 2
“This is likely due to regulatory processes acting beyond mRNA abundance, including post-translational modification, cofactor interactions, dynamic subcellular localisation, and controlled protein turnover [63–67], and demonstrates the value of target-gene-based TF inference.”
c-Myc: an emerging participant in heart failure
Wu, Y. T., Zhang, J., Liu, R., Lin, W., Wang, W., Zhao, Y. Q., Cai, Y. P., Su, H., Sun, W., Zhu, H., et al. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1832539
“This rapid turnover is attributable to its regulation by a variety of post-translational modifications, such as phosphorylation, lactylation, and ubiquitination (26).”
Wang, P., Xu, J., Huang, H., Dong, D., Jiang, X., Wang, F., Hou, B., Shu, M., Bu, L., Zhao, X., et al. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112759
Szychowski, K. A., & Skóra, B. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.117994
Detection of DHRS2-associated E3 Ubiquitin Ligases in Breast Cancer Cell Lines
Abacı, N., Şakar, D., Yaylaz, B. S., & Punar, S. (2026) · Experimed · doi:10.26650/experimed.1789751
Chou, J., Malyukova, A., Bordonaro, A. S., Dygon, K., Litzenburger, L., Dalani, E., Xiao, J., Tümmler, C., Mermelekas, G., Seniveratne, J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.29.745966
The NSDHL/c-Myc/PKM2 Axis Drives Glycolytic Reprogramming and Tumor Growth in Multiple Myeloma
Yue, C., Huang, B.-H., Qi, L., Zhang, X., & Li, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188239
“This event subsequently permits GSK-3 β -mediated Thr58 phosphorylation, Ser62 dephosphorylation, and FBW7-dependent ubiquitination, thereby promoting proteasomal degradation of c-Myc [14,15,34,35].”
Kim, G., Kim, D., Kim, S., & Min, B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.28.755064
Restoration of PP2A AαB56αC trimer formation by RPT04402 molecular glue in high-grade uterine cancer
Peris, I., Haanen, T. J., Day, A., Hu, J., Callahan, C. G., Onishi, G. H., Zawacki, K. P., Tran, B., Harold, A., Dowdican, A. C., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.ady4852
Lupanova, T. N., Georgiev, G. P., & Sobolev, A. S. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18111378
Metadata
- Authors
- Farrell, A. S., & Sears, R. C.
- Affiliations
- Oregon Health & Science University (US)
- ORCID
- Sears, R. C.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2014-03-01
- Volume
- 4
- Issue
- 3
- Pages
- a014365-a014365
- ISSN
- 2157-1422 (ISSN-L)
- PMC
- PMC3935390
- OpenAlex
- W4236967220
- Cited by
- 468
- References
- 114
- Citations by year
- 2026: 35 · 2025: 38 · 2024: 46 · 2023: 58 · 2022: 58 · 2021: 53 · 2020: 55 · 2019: 29 · 2018: 28 · 2017: 17 · 2016: 20 · 2015: 17 · 2014: 10
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- Myc oncoprotein, protein degradation, ubiquitin-proteasome system, MYC protein stability, transcriptional regulation, cancer, MYC-targeted therapy, cell proliferation
- MeSH terms
- Acetylation, Cell Communication, Humans, Neoplasms, Transcription, Genetic, Genes, myc, Ubiquitin, Proteasome Endopeptidase Complex, Protein Stability, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.